Medicare Enrolled
Dr. Tanya Harari, DO
Rheumatology · Wynnewood, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harari?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harari
Dr. Tanya Harari is a rheumatology specialist in Wynnewood, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Harari performed 73,087 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Harari received a total of $14,125 from 43 pharmaceutical and/or device companies across 585 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 18% volume in PA
$14,125 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗73,087
Medicare services
Top 18% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 44,101 | $8 | $20 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
20,000 | $4 | $10 |
| Denosumab injection (Prolia/Xgeva) | 6,962 | $18 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
522 | $11 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
444 | $100 | $212 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
317 | $1 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
190 | $127 | $253 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
170 | $7 | $113 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
110 | $61 | $185 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
75 | $59 | $132 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
64 | $1 | $25 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
40 | $52 | $170 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $129 | $280 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $58 | $154 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $142 | $313 |
| New patient office visit, complex (60-74 min) | 14 | $182 | $308 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
98.9% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,125
Total received (2018-2024)
Avg $2,354/year across 6 years
Top 22% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
585
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,979
2023
$4,547
2022
$1,638
2021
$133
2019
$778
2018
$1,049
Payments by company (2024)
ABBVIE INC.
$1,809
Amgen Inc.
$764
UCB, Inc.
$550
AstraZeneca Pharmaceuticals LP
$541
Novartis Pharmaceuticals Corporation
$400
SUN PHARMACEUTICAL INDUSTRIES INC.
$276
Radius Health, Inc.
$212
Lilly USA, LLC
$192
PFIZER INC.
$189
Genentech USA, Inc.
$107
Mallinckrodt Hospital Products Inc.
$107
Sandoz Inc.
$91
ANI Pharmaceuticals, Inc.
$85
Organon Llc
$83
Kiniksa Pharmaceuticals International, plc
$81
E.R. Squibb & Sons, L.L.C.
$77
Aurinia Pharma U.S., Inc.
$69
Fresenius Kabi USA, LLC
$67
Kyowa Kirin, Inc.
$65
GlaxoSmithKline, LLC.
$61
Alexion Pharmaceuticals, Inc.
$29
GENZYME CORPORATION
$27
Invivyd Inc
$23
DePuy Synthes Sales Inc.
$22
Alvogen Inc
$21
Janssen Biotech, Inc.
$16
Fidia Pharma USA Inc.
$13
Top 3 companies account for 52.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,126
Amgen Inc.
$1,871
AstraZeneca Pharmaceuticals LP
$1,186
UCB, Inc.
$1,134
AbbVie Inc.
$870
Novartis Pharmaceuticals Corporation
$768
PFIZER INC.
$652
Radius Health, Inc.
$504
Lilly USA, LLC
$340
Janssen Biotech, Inc.
$335
AbbVie, Inc.
$333
Aurinia Pharma U.S., Inc.
$324
SUN PHARMACEUTICAL INDUSTRIES INC.
$310
Actelion Pharmaceuticals US, Inc.
$293
Janssen Scientific Affairs, LLC
$214
Janssen Pharmaceuticals, Inc
$214
Genentech USA, Inc.
$202
Mallinckrodt Hospital Products Inc.
$201
Alexion Pharmaceuticals, Inc.
$195
Sandoz Inc.
$177
GlaxoSmithKline, LLC.
$172
GENZYME CORPORATION
$170
Kyowa Kirin, Inc.
$143
ANI Pharmaceuticals, Inc.
$127
PORTOLA PHARMACEUTICALS, INC.
$122
Allergan Inc.
$122
Regeneron Healthcare Solutions, Inc.
$122
Fresenius Kabi USA, LLC
$107
Lundbeck LLC
$104
Kiniksa Pharmaceuticals, Ltd.
$86
Organon Llc
$83
Kiniksa Pharmaceuticals International, plc
$81
E.R. Squibb & Sons, L.L.C.
$77
Exeltis, USA Inc.
$66
DePuy Synthes Sales Inc.
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Novo Nordisk Inc
$48
Organon LLC
$32
Celltrion USA Inc.
$26
Invivyd Inc
$23
Alvogen Inc
$21
Pacira Pharmaceuticals Incorporated
$17
Fidia Pharma USA Inc.
$13
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · AVYCAZ · Actemra · Arcalyst · BENLYSTA · BEVYXXA · Bimzelx · Briviact · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUPIXENT · ELIQUIS · EVENITY · Enbrel · Erivedge · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · Ilumya · KEVZARA · LUPKYNIS · ONFI · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PEMGARDA · PURIFIED CORTROPHIN GEL · REMICADE · RINVOQ · Rituxan · SAPHNELO · SKYRIZI · STELARA · STRENSIQ · Skyrizi · Sodium Chloride · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tremfya · Tymlos · UPTRAVI · Wegovy · Winlevi · XARELTO · XELJANZ · YUFLYMA · ZEPBOUND · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
175
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harari is a mixed practice specialist, with above-average Medicare volume (top 18% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harari experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Harari performed 44,101 romosozumab injection (evenity) for osteoporosis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Harari receive payments from pharmaceutical companies?
Yes. Dr. Harari received a total of $14,125 from 43 companies across 585 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harari's costs compare to other rheumatologists in Wynnewood?
Dr. Harari's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Wynnewood
Browse rheumatologists in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology